- Home
- GGG vs ICLR Comparison
GGG vs ICLR Comparison
Compare GGG & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GGG
- ICLR
- Stock Information
- Founded
- GGG 1926
- ICLR 1990
- Country
- GGG United States
- ICLR Ireland
- Employees
- GGG N/A
- ICLR N/A
- Industry
- GGG Fluid Controls
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- GGG Industrials
- ICLR Health Care
- Exchange
- GGG Nasdaq
- ICLR Nasdaq
- Market Cap
- GGG 14.5B
- ICLR 16.4B
- IPO Year
- GGG N/A
- ICLR 1998
- Fundamental
- Price
- GGG $83.93
- ICLR $193.27
- Analyst Decision
- GGG Hold
- ICLR Strong Buy
- Analyst Count
- GGG 3
- ICLR 12
- Target Price
- GGG $87.00
- ICLR $283.45
- AVG Volume (30 Days)
- GGG 801.4K
- ICLR 966.3K
- Earning Date
- GGG 01-27-2025
- ICLR 02-19-2025
- Dividend Yield
- GGG 1.31%
- ICLR N/A
- EPS Growth
- GGG N/A
- ICLR 44.49
- EPS
- GGG 2.82
- ICLR 8.99
- Revenue
- GGG $2,113,315,999.00
- ICLR $8,306,823,000.00
- Revenue This Year
- GGG $6.94
- ICLR $3.99
- Revenue Next Year
- GGG $6.81
- ICLR $2.19
- P/E Ratio
- GGG $29.75
- ICLR $21.75
- Revenue Growth
- GGG N/A
- ICLR 3.63
- 52 Week Low
- GGG $77.49
- ICLR $183.38
- 52 Week High
- GGG $94.77
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- GGG 47.20
- ICLR 35.59
- Support Level
- GGG $81.38
- ICLR $192.93
- Resistance Level
- GGG $84.86
- ICLR $204.33
- Average True Range (ATR)
- GGG 1.44
- ICLR 6.25
- MACD
- GGG 0.03
- ICLR -0.73
- Stochastic Oscillator
- GGG 48.39
- ICLR 2.49
About GGG Graco Inc.
Graco manufactures equipment used for managing fluids, coatings, and adhesives, specializing in difficult-to-handle materials. Graco's business is organized into three segments: industrial, process, and contractor. The Minnesota-based firm serves a wide range of end markets, including industrial, automotive, and construction, and its broad array of products include pumps, valves, meters, sprayers, and equipment used to apply coatings, sealants, and adhesives. The firm generated roughly $2.2 billion in sales in 2023.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.